Etiopathology, clinical features, and treatment of diffuse and multinodular nontoxic goiters

Journal of Endocrinological Investigation

Volumn 39, Issue 4, 2016, Pages 357-373

  Knobel, M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Clinical evaluation; Multinodular goiter; Physiopathology; Treatment

Indexed keywords

IODINE; IRON; LEVOTHYROXINE; RADIOACTIVE IODINE; RECOMBINANT THYROTROPIN; SELENIUM; THIAMAZOLE; THYROTROPIN;

CANCER RISK; CLINICAL FEATURE; CLINICAL OBSERVATION; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; FINE NEEDLE ASPIRATION BIOPSY; HUMAN; HYPERTHYROIDISM; IODINE DEFICIENCY; LABORATORY TEST; NODULAR GOITER; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATIVE STRESS; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; REVIEW; SCINTIGRAPHY; THYROID HORMONE SYNTHESIS; THYROID HYPERPLASIA; THYROID PAPILLARY CARCINOMA; THYROTROPIN BLOOD LEVEL; TOXICITY; GOITER, NODULAR; PATHOLOGY; PROGNOSIS;

GOITER, NODULAR; HUMANS; PROGNOSIS;

EID: 84962494373     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.1007/s40618-015-0391-7     Document Type: Review

References (82)

1. Studer H, Peter HJ, Gerber H (1989) Natural heterogeneity of thyroid cells: the basis for understanding thyroid function and nodular goiter. Endocr Rev 10:125-135
2. Hegedus L, Bonnema SJ, Bennedbaek FN (2003) Management of simple nodular goiter: current status and future perspectives. Endocr Rev 24:102-132
3. Delange F, de Benoist B, Pretell E, Dunn JT (2001) Iodine deficiency in the world: where do we stand at the turn of the century? Thyroid 11:437-447
4. Knudsen N, Bulow I, Jorgensen T, Laurberg P, Ovesen L, Perrild H (2000) Goitre prevalence and thyroid abnormalities at ultrasonography: a comparative epidemiological study in two regions with slightly different iodine status. Clin Endocrinol (Oxf) 53:479-485
5. Knudsen N, Perrild H, Christiansen E, Rasmussen S, Dige-Petersen H, Jorgensen T (2000) Thyroid structure and size and two-year follow-up of solitary cold thyroid nodules in an unselected population with borderline iodine deficiency. Eur J Endocrinol 142:224-230
6. Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, Grimley EJ, Hasan DM, Rodgers H, Tunbridge F (1995) The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 43:55-68
7. Chan JKC, Hirokawa M, Evans H, Williams ED, Osamura Y, Cady B et al (2004) Follicular adenoma. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C (eds) WHO classification of tumours. Pathology and genetics of tumours of endocrine organs, 4th edn. Iarc Press, Lyon, pp 98-103
8. Medeiros-Neto G, Knobel M (2010) Iodine deficiency disorders. In: Jameson JL, DeGroot LJ (eds) Endocrinology, 6th edn. Elsevier, Philadelphia, pp 2129-2145
9. Knobel M, Medeiros-Neto G (2007) Pediatric aspects of thyroid function and iodine. In: Krassas GE, Rivkees SA, Kiess W (eds) Diseases of the thyroid in childhood and adolescence. Pediatr Adolesc Med, Karger, Basel, pp 56-79
10. Knobel M, Bisi H, Peres CA, Medeiros-Neto G (1993) Correlated functional and morphological aspects in human multinodular simple goiter. Endocr Pathol 4:205-214
11. Furlanetto TW, Nguyen LQ, Jameson JL (1999) Estradiol increases proliferation and down-regulates the sodium/iodide symporter gene in FRTL-5 cells. Endocrinology 140:5705-5711
12. Manole D, Schildknecht B, Gosnell B, Adams E, Derwahl M (2001) Estrogen promotes growth of human thyroid tumor cells by different molecular mechanisms. J Clin Endocrinol Metab 86:1072-1077
13. Brix TH, Hansen PS, Kyrik KO, Hegedus L (2000) Cigarette smoking and clinically overt thyroid disease: a population-based twin case-control study. Arch Int Med 160:661-666
14. Knudsen N, Laurberg P, Perrild H, Bülow I, Ovesen L, Jørgensen T (2002) Risk factors for goiter and thyroid nodules. Thyroid 12:879-888
15. Spinos N, Terzis G, Crysanthopoulou A, Adonakis G, Markou KB, Vervita V, Koukouras D, Tsapanos V, Decavalas G, Kourounis G, Georgopoulos NA (2007) Increased frequency of thyroid nodules and breast fibroadenomas in women with uterine fibroids. Thyroid 17:1257-1259
16. Knudsen N, Bülow I, Laurberg P, Perrild H, Ovesen L, Jørgensen T (2002) Low goitre prevalence among users of oral contraceptives in a population sample of 3712 women. Clin Endocrinol (Oxf) 57:71-76
17. Cappelli C, Castellano M, Pirola I, De Martino E, Gandossi E, Delbarba A, Salvi A, Rosei EA (2008) Reduced thyroid volume and nodularity in dyslipidaemic patients on statin treatment. Clin Endocrinol (Oxf) 68:16-21
18. Gaitan E, Cooksey RC, Legan J, Lindsay RH, Ingbar SH, Medeiros-Neto G (1994) Antithyroid effects in vivo and in vitro of Babassu and Mandioca: staple foods in goiter areas of Brazil. Eur J Endocrinol 31:138-144
19. Suzuki H, Higuchi S, Ohtaki S, Horiuchi Y (1965) "Endemic coast goitre" in Hokkaido, Japan. Acta Endocrinol 50:161-176
20. Lazarus JH (2009) Lithium and thyroid. Best Pract Res Clin Endocrinol Metab 23:723-733
21. Boas M, Main KM, Feldt-Rasmussen U (2009) Environment chemicals and thyroid function: an update. Curr Opin Endocrinol Diabetes Obes 16:385-391
22. Krohn K, Fuhrer D, Bayer Y, Eszlinger M, Brauer V, Neumann S, Paschke R (2005) Molecular pathogenesis of euthyroid and toxic multinodular goiter. Endocr Rev 26:504-524
23. Brix TH, Kyvik KO, Hegedus L (1999) Major role of genes in the etiology of simple goiter in females: a population - based twin study. J Clin Endocrinol Metab 84:3071-3075
24. Hansen PS, Brix TH, Bennedbaek FN, Bonnema SJ, Kyvik KO, Hegedus L (2004) Genetic and environmental causes of individual differences in thyroid size: a study of healthy Danish twins. J Clin Endocrinol Metab 89:2071-2077
25. Bignell GR, Canzian F, Shayeghi M, Stark M, Shugart YY, Biggs P, Mangion J, Hamoudi R, Rosenblatt J, Buu P, Sun S, Stoffer SS, Goldgar DE, Romeo G, Houlston RS, Narod SA, Stratton MR, Foulkes WD (1997) Familial nontoxic multinodular thyroid goiter locus maps to chromosome 14q but does not account for familial nonmedullary thyroid cancer. Am J Hum Genet 61:1123-1130
26. - symporter. J Clin Endocrinol Metab 84:3750-3756
27. Capon F, Tacconelli A, Giardina E, Sciacchitano S, Bruno R, Tassi V, Trischitta V, Filetti S, Dallapiccola B, Novelli G (2000) Mapping a dominant form of multinodular goiter to chromosome Xp22. Am J Hum Genet 67:1004-1007
28. Bayer Y, Neumann S, Meyer B, Ruschendorf F, Reske A, Brix T, Hegedus L, Langer P, Nurnberg P, Paschke R (2004) Genome-wide linkage analysis reveals evidence for four new susceptibility loci for familial euthyroid goiter. J Clin Endocrinol Metab 89:4044-4052
29. Maier J, van Steeg H, van Oostrom C, Paschke R, Weiss RE, Krohn K (2007) Iodine deficiency activates antioxidant genes and causes DNA damage in the thyroid gland of rats and mice. Biochim Biophys Acta 1773:990-999
30. Cooke MS, Evans MD, Dizdaroglu M, Lunec J (2003) Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J 17:1195-1214
31. Rentsch H, Studer H, Frauchiger B, Siebenhüner L (1981) Topographical heterogeneity of basal and thyrotropin-stimulated adenosine 3′5′-monophosphate in human nodular goiter. J Clin Endocrinol Metab 53:514-521
32. Berghout A, Wiersinga WM, Smits NJ, Touber JL (1990) Interrelationships between age, thyroid volume, thyroid nodularity, and thyroid function in patients with sporadic nontoxic goiter. Am J Med 89:602-608
33. Aghini-Lombardi F, Antonangeli L, Martino E, Vitti P, Maccherini D, Leoli F, Rago T, Grasso L, Valeriano R, Balestrieri A, Pinchera A (1999) The spectrum of thyroid disorders in an iodine-deficient community: the Pescopagano survey. J Clin Endocrinol Metab 84:561-566
34. Wiener JD, de Vries AA (1979) On the natural history of Plummer's disease. Clin Nucl Med 4:181-190
35. Elte JW, Bussemaker JK, Haak A (1990) The natural history of euthyroid multinodular goitre. Postgrad Med J 66:186-190
36. Pemberton HS (1946) Sign of submerged goitre. Lancet 251:509
37. O'Brien KE, Gopal V, Mazzaferri E (2003) Pemberton's sign associated with a large multinodular goiter. Thyroid 13:407-408
38. Levin R, Newman SA, Login IS (1986) Bilateral Horner's syndrome secondary to multinodular goiter. Ann Intern Med 105:550-551
39. Gemsenjäger E, Staub JJ, Girard J, Heitz P (1976) Preclinical hyperthyroidism in multinodular goiter. J Clin Endocrinol Metab 43:810-816
40. Medeiros-Neto G (2009) Iodine nutrition in Brazil: where do we stand? Arq Bras Endocrinol Metabol 53:470-474
41. Bisi H, Fernandes VSO, Camargo RYA, Koch L, Abdo AH, Brito T (1989) The prevalence of unsuspected thyroid pathology in 300 sequential autopsied with special reference to incidental carcinoma. Cancer 64:1888-1893
42. Belfiore A, La Rosa GL, La Porta GA, Giuffrida D, Milazzo G, Lupo L, Regalbuto C, Vigneri R (1992) Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age and multinodularity. Am J Med 93:363-369
43. Pelizzo MR, Bernant P, Toniato A, Fassina A (1997) Frequency of thyroid carcinoma is a recent series of 539 consecutive thyroidectomies for multinodular goiter. Tumori 83:653-655
44. Hegedus L (2004) The thyroid nodule. N Engl J Med 351:1764-1771
45. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ (2005) Cancer statistics, 2005. CA Cancer J Clin 55:10-30
46. Elisei R, Bottici V, Luchetti F, Di Coscio G, Romei C, Grasso L, Miccoli P, Iacconi P, Basolo F, Pinchera A, Pacini F (2004) Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders. J Clin Endocrinol Metab 89:163-168
47. Camargo RY, Tomimori EK, Knobel M, Medeiros-Neto G (2007) Preoperative assessment of thyroid nodules: role of ultrasonography and fine needle aspiration biopsy followed by cytology. Clinics (Sao Paulo) 62:411-418
48. Mandel SJ (2004) Diagnostic use of ultrasonography in patients with nodular thyroid disease. Endocr Pract 10:246-252
49. Moon WJ, Jung SL, Lee JH, Na DG, Baek JH, Lee YH, Kim J, Kim HS, Byun JS, Lee DH, Thyroid Study Group, Korean Society of Neuro- and Head and Neck Radiology (2008) Benign and malignant thyroid nodules: US differentiation: Multicenter retrospective study. Radiology 247:762-770
50. Papini E, Guglielmi R, Bianchini A, Crescenzi A, Taccogna S, Nardi F, Panunzi C, Rinaldi R, Toscano V, Pacella CM (2002) Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. J Clin Endocrinol Metab 87:1941-1946
51. Papini E (2003) The dilemma of non-palpable thyroid nodules. J Endocrinol Invest 26:3-4
52. Hagag P, Strauss S, Weiss M (1998) Role of ultrasound-guided fine-needle aspiration biopsy in evaluation of nonpalpable thyroid nodules. Thyroid 18:989-995
53. Cappelli C, Castellano M, Pirola I, Gandossi E, De Martino E, Cumetti D, Agosti B, Rosei EA (2006) Thyroid nodule shape suggests malignancy. Eur J Endocrinol 155:27-31
54. Ito Y, Uruno T, Nakano K, Takamura Y, Miya A, Kobayashi K, Yokozawa T, Matsuzuka F, Kuma S, Kuma K, Miyauchi A (2003) An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid 13:381-387
55. Hays MT, Wesselossky B (1973) Simultaneous measurement of thyroidal trapping (99mTcO4-) and binding (131I-): clinical and experimental studies in man. J Nucl Med 14:785-792
56. Bahn RS, Castro MR (2011) Approach to the patient with nontoxic multinodular goiter. J Clin Endocrinol Metab 96:1202-1211
57. Bloom AD, Adler LP, Shuck JM (1993) Determination of malignancy of thyroid nodules with positron emission tomography. Surgery 114:728-734
58. Gharib H, Papini E, Paschke R, Duick DS, Valcavi R, Hegedüs L, Vitti P, AACE/AME/ETA Task Force on Thyroid Nodules (2010) American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: executive summary of recommendations. Endocr Pract 16:468-475
59. Samuels MH (2001) Evaluation and treatment of sporadic nontoxic goiter - some answers and more questions [editorial]. J Clin Endocrinol Metab 86:994-997
60. Hintze G, Kobberling J (1992) Treatment of iodine deficiency goiter with iodine, levothyroxine or a combination of both. Thyroidology 4:37-40
61. Güllü S, Gürses MA, Başkal N, Uysal AR, Kamel AN, Erdoʇan G (1999) Suppressive therapy with levothyroxine for euthyroid diffuse and nodular goiter. Endocr J 46:221-226
62. Diehl LA, Garcia V, Bonnema SJ, Hegedüs L, Albino CC, Graf H; Latin American Thyroid Society (2005) Management of the nontoxic multinodular goiter in Latin America: comparison with North America and Europe, an electronic survey. J Clin Endocrinol Metab 90:117-123
63. Berghout A, Wiersinga WM, Drexhage HA, Smits NJ, Touber JL (1990) Comparison of placebo with L-thyroxine alone or with carbimazole for treatment of sporadic non-toxic goitre. Lancet 336:193-197
64. Puzziello A, Carrano M, Angrisani E, Marotta V, Faggiano A, Zeppa P, Vitale M (2014) Evolution of benign thyroid nodules under levothyroxine non-suppressive therapy. J Endocrinol Invest 37:1181-1186
65. Fiore E, Rago T, Provenzale MA, Scutari M, Ugolini C, Basolo F, Di Coscio G, Miccoli P, Grasso L, Pinchera A, Vitti P (2010) L-thyroxine-treated patients with nodular goiter have lower serum TSH and lower frequency of papillary thyroid cancer: results of a cross-sectional study on 27914 patients. Endocr Relat Cancer 17:231-239
66. Agarwal G, Aggarwal V (2008) Is total thyroidectomy the surgical procedure of choice for benign multinodular goiter? An evidence-based review. World J Surg 32:1313-1324
67. Moalem J, Suh I, Duh QY (2008) Treatment and prevention of recurrence of multinodular goiter: an evidence-based review of the literature. World J Surg 32:1301-1312
68. Yoldas T, Makay O, Icoz G, Kose T, Gezer G, Kismali E, Tamsel S, Ozbek S, Yllmaz M, Akyildiz M (2015) Should subtotal thyroidectomy be abandoned in multinodular goiter patients from endemic regions requiring surgery? Int Surg 100:9-14
69. Thomusch O, Machens A, Sekulla C, Ukkat J, Lippert H, Gastinger I, Dralle H (2000) Multivariate analysis of risk factors for postoperative complications in benign goiter surgery: prospective multicenter study in Germany. World J Surg 24:1335-1341
70. Bauer PS, Murray S, Clark N, Pontes DS, Sippel RS, Chen H (2013) Unilateral thyroidectomy for the treatment of benign multinodular goiter. J Surg Res 184:514-518
71. Mercante G, Gabrielli E, Pedroni C, Formisano D, Bertolini L, Nicoli F, Valcavi R, Barbieri V (2010) CT cross-sectional imaging classification system for substernal goiter based on risk factors for an extracervical surgical approach. Head Neck 33:792-799
72. Pieracci FM, Fahey TJ 3rd (2007) Substernal thyroidectomy is associated with increased morbidity and mortality as compared with conventional cervical thyroidectomy. J Am Coll Surg 205:1-7
73. Baehr KM, Lyden E, Treude K, Erickson J, Goldner W (2012) Levothyroxine dose following thyroidectomy is affected by more than just body weight. Laryngoscope 122:834-838
74. Ross DS (1992) Thyroid hormone suppressive therapy of sporadic nontoxic goiter. Thyroid 2:263-269
75. Bonnema SJ, Hegedüs L (2012) Radioiodine therapy in benign thyroid diseases: effects, side effects, and factors affecting therapeutic outcome. Endocr Rev 33:920-980
76. Bonnema SJ, Bertelsen H, Mortensen J, Andersen PB, Knudsen DU, Bastholt L, Hegedüs L (1999) The feasibility of high dose iodine 131 treatment as an alternative to surgery in patients with a very large goiter: effect on thyroid function and size and pulmonary function. J Clin Endocrinol Metab 84:3636-3641
77. Bonnema SJ, Fast S, Hegedüs L (2014) The role of radioiodine therapy in benign nodular goiter. Best Practice Res Clin Endocrinol Metabol 28:519-631
78. Medeiros-Neto G, Marui S, Knobel M (2008) An outline concerning the potential use of recombinant human thyrotropin for improving radioiodine therapy of multinodular goiter. Endocrine 33:109-117
79. Paz-Filho GJ, Mesa-Junior CO, Olandoski M, Woellner LC, Goedert CA, Boguszewski CL, Carvalho GA, Graf H (2007) Effect of 30 mCi radioiodine on multinodular goiter previously treated with recombinant human thyroid-stimulating hormone. Braz J Med Biol Res 40:1661-1670
80. Romão R, Rubio IGS, Tomimori EK, Camargo RY, Knobel M, Medeiros-Neto G (2009) High prevalence of side effects after rhTSH stimulated radioiodine treatment with 30 mCi in patients with multinodular goiter and subclínical/clínical hyperthyroidism. Thyroid 19:945-951
81. Fast S, Nielsen VE, Bonnema SJ, Hegedüs L (2009) Time to reconsider nonsurgical therapy of benign non-toxic multinodular goitre: focus on recombinant human TSH augmented radioiodine therapy. Eur J Endocrinol 160:517-528
82. Albino CC, Graf H, Sampaio AP, Vigário A, Paz-Filho GJ (2008) Thiamazole as an adjuvant to radioiodine for volume reduction of multinodular goiter. Expert Opin Investig Drugs 17:1781-1786